SENP1 and cancer: Concerning the association of SENP1 expression with prognosis in patients with cancer, higher plasma exosome-derived SENP1 correlates with worse DFS and OS in patients with osteosarcoma (23); additionally, SENP1 overexpression independently correlates with poor prognosis in patients with NSCLC (11).